Table 3.
Conjoint relations of TIMP-1 and PIIINP to the risk of death and CVD.
| Adjusted HR* (CI) | p-value | |
|---|---|---|
| A. Death (n = 808; 44 events) | ||
| Log-TIMP-1 | 1.60 (1.19 – 2.15) | 0.002 |
| Log-PIIINP | 1.41 (1.03 – 1.92) | 0.03 |
| B. CVD (n = 808; 64 events) | ||
| Log-TIMP-1 | 1.04 (0.79 – 1.37) | 0.77 |
| Log-PIIINP | 1.35 (1.05 – 1.74) | 0.02 |
HR = hazards ratio; CI = confidence interval; TIMP-1 = tissue inhibitor of matrix metalloproteinase; PIIINP = procollagen type III amino-terminal peptide.
HR per standard deviation change in biomarker levels, adjusted for age, sex, BMI, systolic blood pressure, hypertension treatment, diabetes, total/HDL cholesterol ratio, current smoking, LV mass and LV sampling group.